Xenon Pharmaceuticals (XENE) shares were down nearly 26% in premarket trading Friday after the company paused enrollment of new patients in studies for major depressive disorder and bipolar depression.
Digital Currency X Technology (DCX) stock was more than 19% lower following a 38% rise in Thursday's session.
ALX Oncology (ALXO) stock was 8% lower, extending the 1% loss from Thursday's session.
Stewards (SWRD) shares were down 8%, partially reversing the 18% rise at the prior close.
Hotel101 Global (HBNB) stock was 7% lower following a 0.9% advance.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.